NSAID-induced polyp regression in familial adenomatous polyposis patients

Gastroenterology Clinics of North America

Volumn 25, Issue 2, 1996, Pages 349-361

  Giardiello, F M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; SULINDAC;

ADENOMATOUS POLYP; COLON CARCINOGENESIS; COLORECTAL CANCER; FAMILIAL POLYPOSIS; HUMAN; NONHUMAN; ORAL DRUG ADMINISTRATION; REMISSION; REVIEW;

EID: 0029896486     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70251-X     Document Type: Article

References (63)

1. D. Ahnen D. Alberts L. Hixson The sulfone metabolite of sulindac (FGN-1) inhibits rat colonic carcinogenesis but does not inhibit either prostaglandin synthesis or colonic proliferation Gastroenterology 108 1995 A444
2. P.H. Bishop J.A. Awad R. DuBois Inhibition of immediate early gene expression by sulindac sulfide in rat epithelial cells Gastroenterology 106 1994 A372
3. P.M. Brooks A.J.J. Wood Nonsteroidal antiinflammatory drugs—differences and similarities N Engl J Med 324 1991 1716 1722
4. H.J.R. Bussey Familial Polyposis coli: Family Studies, Histopathology, Differential Diagnosis, and Results of Treatment 1975 Johns Hopkins University Press Baltimore
5. J. Charneau N. D'Aubigny P. Burtin Micropolypes rectaux apres colectomie totale pour polypose familiale: Efficacite' du sulindac Gastroenterol Clin Bio 14 1990 153 157
6. H.S. Debinski J. Trojan S. Love Sulindac has maximal effect on small but not large polyps in the duodenum in patients with familial adenomatous polyposis Gastroenterology 108 1995 A460
7. D.E. Duggan K.F. Hooke E.A. Risley Identification of the biologically active form of sulindac J Pharmacol Exp Therap 201 1977 8 13
8. D.L. Earnest L.J. Hixson D.S. Alberts Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemoprevention J Cell Biochem 161 suppl 1992 156 166
9. D.L. Earnest L.J. Hixson W.W. Sim Piroxicam as an agent to inhibit colonic neoplasia Gastroenterology 96 1989 A134
10. C.E. Eberhart R.J. Coffey A. Radhika Upregulation of cyclooxygenase-2 gene expression in human colorectal polyps and adenocarcinoma Gastroenterology 107 1994 1183 1188
11. E.J. Gardner R.C. Richards Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis Am J Hum Genet 5 1953 139
12. F.M. Giardiello S.R. Hamilton A.J. Krush Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 398 1993 1313 1316
13. R.A.F. Gonzaga F.R. Lima S. Carneiro Sulindac treatment for familial polyposis Lancet 1 1985 751
14. R. Hanif A. Pittas Y. Feng NSAIDs inhibit the growth of colon cancer cell lines by a prostaglandin independant pathway Gastroenterology 108 1995 A478
15. L.J. Hixson D.L. Earnest M.B. Fennerty NSAID effect on sporadic colon polyps Am J Gastroenterol 88 1993 1652 1656
16. H.B. Hucker S.C. Stauffer S.D. White Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)-benzylidenyl]-indene-3-acetic acid in the rat, dog, rhesus monkey, and man Drug Metab Disposition 1 1973 721 736
17. G.J. Kelloff W.F. Malone C.W. Boone Progress in applied chemoprevention research Semin Oncol 17 1990 438 455
18. K.W. Kinzler M.C. Nilbert L.K. Su Identification of FAP locus genes from chromosome 5q21 Science 253 1991 661 665
19. M. Koutsos S.J. Shiff L. Qiao Aspirin and other NSAIDs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis Gastroenterology 108 1995 A478
20. T. Kudo T. Narisawa S. Abo Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats Gann 71 1980 260 264
21. D. Labayle D. Fischer J.P. Hagege Efficacité du sulindac dans le traitement de la polypose rectocolique Gastroenterol Clin Biol 10 1986 436
22. D. Labayle D. Fischer P. Vielh Sulindac causes regression of rectal polyps in familial adenomatous polyposis Gastroenterology 101 1991 635 639
23. M. Lipkin Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colon cancer Cancer 34 1974 878 888
24. U. Metzger J. Meier G. Uhlschmid Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer Dis Colon Rectum 27 1984 366 369
25. M. Moorghen P. Ince K.J. Finney A protective effect of sulindac against chemically-induced primary colonic tumors in mice J Pathol 156 1988 341 347
26. M. Moorghen P. Ince K.J. Finney The effect of sulindac on colonic tumour formation in dimethylhydrazine-treated mice Acta Histochem 39 suppl 1990 195 199
27. A.R. Moser W.F. Dove K.A. Roth MIN (multiple intestinal neoplasia) mutation: Its effect on gut epithelial cell differentiation and interaction with a modifier system J Cell Biol 116 1992 1517 1526
28. A.R. Moser H.C. Pitot W.F. Dove A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse Science 247 1990 322 324
29. A. Muller R. Hurlimann C. Meyenberger Sulindac in familial adenomatous polyposis coli preliminary findings of a prospective study Schweiz Med Wochenschr 124 1994 651 654
30. T. Narisawa P. Hermanek M. Habs Reduction of acetoxymethyl-methylnitrosamine induced large bowel cancer by indomethacin Tohoku J Exp Med 144 1984 237 243
31. 2) against indomethacin J Cancer Res Clin Oncol 108 1984 239 242
32. T. Narisawa M. Sato M. Sano Inhibition of development of methylnitrosourea-induced rat colonic tumors by peroral administration of indomethacin Gann 73 1982 377 381
33. T. Narisawa M. Sato M. Tani Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment Cancer Res 41 1981 1954 1957
34. T. Narisawa M. Satoh M. Sano Inhibition of initiation and promotion by N-methylnitrosurea-induced colon carcinogenesis in rats by non-steroidal anti-inflammatory agent indomethacin Carcinogenesis 4 1983 1225 1227
35. N.D. Nigro A.W. Bull M.E. Boyd Inhibition of intestinal carcinogenesis in rats: Effect of difluoromethylornithine with piroxicam or fish oil J Natl Cancer Inst 77 1986 1309 1313
36. I. Nishisho Y. Nakamura Y. Miyoshi Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients Science 253 1991 665 669
37. Y. Niv G.M. Fraser Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy Gastroenterology 107 1994 854 857
38. Nonsteroidal anti-inflammatory agents McEvoy G. AHFS Drug Information 1993 The American Society of Hospital Pharmacists, Inc Bethesda, MD 1201 1205
39. K.P. Nugent K.C.R. Farmer A.D. Spigelman Randomized controlled clinical trial of sulindac on intestinal polyposis in FAP Br J Surg 80 1993 1618 1619
40. P.J. Pasricha A. Bedi K. O'Connor The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis Gastroenterology 109 1995 994 998
41. M. Pollard P.H. Luckert Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosurea Cancer Lett 25 1984 117 121
42. M. Pollard P.H. Luckert Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors Cancer Treat Rep 64 1980 1323 1327
43. M. Pollard P.H. Luckert Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine Science 214 1981 558 559
44. M. Pollard P.H. Luckert Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats J Natl Cancer Inst 70 1983 1103 1105
45. M. Pollard P.H. Luckert Prevention and treatment of primary intestinal tumors in rats by piroxicam Cancer Res 49 1989 6471 6473
46. M. Pollard P.H. Luckert M.A. Schmidt The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat Cancer Lett 21 1983 57 61
47. S. Powell N. Zilz Y. Barclay APC mutations occur early during colorectal carcinogenesis Nature 359 1992 235 237
48. C.V. Rao K. Tokumo J. Rigotty Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-diflouromethylornithine, 16α-flour-5-androsten-17-one, and ellagic acid individually and in combination Cancer Res 51 1991 4528 4534
49. B.S. Reddy H. Maruyama G. Kelloff Dose related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development Cancer Res 47 1987 5340 5346
50. B.S. Reddy J. Nayini K. Tokumo Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with DL-&-diflouromethylornithine, an ornithine decarboxylase inhibitor, in diet Cancer Res 50 1990 2562 2568
51. B.S. Reddy C.V. Rao A. Rivenson Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats Carcinogenesis 14 1993 1493 1497
52. J. Rigau J.M. Pique E. Rubio Effects of long-term sulindac therapy on colonic polyposis Ann Intern Med 115 1991 952 954
53. D.S. Ross D. Bitzer T. Roy Piroxicam inhibits the growth of an adenocarcinoma isograft in Fischer rats J Surg Res 45 1988 249 253
54. M. Sato T. Narisawa M. Sano Growth inhibition of transplantable murine colon adenocarcinoma 38 by indomethacin J Cancer Res Clin Oncol 106 1983 21 26
55. T.Y. Shen C.A. Winter Chemical and biological studies on indomethacin, sulindac and their analogs Adv Drug Res 12 1977 89 245
56. S.A. Skinner A.G. Penny P.E. O'Brien Sulindac inhibits the rate of growth and development of colon tumors in the rat Gastroenterology 100 1990 A403
57. M.T. Spagnesi F. Tonelli P. Dolara Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment Gastroenterology 106 1994 362 366
58. O.T. Terpstra M. van Blankenstern J. Dees Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer Gastroenterology 92 1987 704 708
59. A.G. Thorson H.T. Lynch T.C. Smyrk Rectal cancer in FAP patient after sulindac Lancet 343 1994 180
60. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs Nature (New Biol) 231 1971 232 235
61. W.R. Waddell G.F. Ganser E.J. Cerise Sulindac for polyposis of the colon Am J Surg 157 1989 175 179
62. W.R. Waddell R.W. Loughry Sulindac for polyposis of the colon J Surg Oncol 24 1983 83 87
63. G. Winde H.G. Gumbinger H. Osswald The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: Clinical results of a dose-finding study on rectal sulindac administration Int J Colorec Dis 8 1993 13 17